Apr 01,2016

Introducing Beta Bionics: Bringing the iLet Bionic Pancreas to Market

Breaking news today from Boston, where Dr. Ed Damiano of the Bionic Pancreas team disclosed the launch of “Beta Bionics” – a new “public benefit corporation” to commercialize the team’s fully integrated iLet Bionic Pancreas device to automate delivery of insulin and glucagon. Lilly has also invested $5 million in Beta Bionics, a major vote of confidence in the team. The company’s website went live today at betabionics.com.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jun 01,2016

Fruit Street Health raises additional $1.4M in crowdfunding push for telehealth

Fruit Street Health, a telehealth startup with a joint venture with VSee, has raised $5.4 million in the past year from 120 physicians a crowdfunding push, according to an amended Form D filing with the U.S. Securities and Trade Commission. In November, Fruit Street announced it had raised $4 million from 60 physicians. The amended filing shows it has raised an additional $1.4 million since then from 50 more doctors.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Dec 20,2016

Indigo Announces Successful Series A Financing Round

Indigo Diabetes, a spin-off from Ghent University and imec, today announces the successful closure of a 7 million Euros series-A financing round. The funding is provided by an international investment syndicate led by Thuja Capital Healthcare Fund II and PMV, and includes Sensinnovat, Parana Management Corp, Qbic Arkiv Fund, Fidimec, SOFI, Manuardeo and Capricorn ICT Arkiv as co-investors. This financing success will fuel the company’s development towards measuring and managing blood glucose levels without the need for finger pricks.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Feb 01,2017

Novo Nordisk Partners with Beta Bionics and Invests $5 Million

Beta Bionics shared exclusive breaking news with diaTribe today that it has received an impressive $5 million investment from insulin maker Novo Nordisk in its newest strategic partnership. This very meaningful development will help the Boston-based “public benefit corporation” advance its fully integrated iLet Bionic Pancreas device that automates delivery of insulin and insulin and glucagon (via Dexcom CGM and a smart algorithm).

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 08,2017

With $37 million in funding, health startup Virta aims to cure type 2 diabetes by watching what you eat

The company has so far pulled in $37 million in funding from VC firms Venrock, Allen & Company, Ev Williams’ Obvious Ventures, Redmile Group, and PayPal and Affirm founder Max Levchin’s Scifi VC to study new treatment options that could reverse the disorder.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jun 27,2017

DayTwo Secures $12.0 Million Series A Financing Round

DayTwo, a leader in microbiome-health management, announced today it has completed a $12.0 million Series A round of financing through Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Seventure Partners' Health for Life Capital fund, Mayo Clinic, co-founder Marius Nacht, and other private investors.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Aug 04,2017

Fruit Street finds more physician investors in $3M fundraise for DPP

Nutrition focused telehealth startup Fruit Street Health had raised $3 million from physician investors in a fresh round of funding this week. The New York company integrates telemedicine, activity trackers, and medical devices into a program to help physicians and dieticians monitor and check in with patients as part of a diabetes prevention program. DPP is a structured intervention program designed to halt people deemed at risk.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Sep 19,2017

Diabetes: will the French Diabeloop disrupt the market with its "artificial pancreas"?

The French startup, which has just raised 13.5 million euros, plans to launch its connected insulin pump for type 1 diabetics on the European and American markets in 2018 and 2019. If its device is not fully automated , Diabeloop believes it has the most efficient system in the world.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Oct 09,2017

Funding success for digital health start-up Gendius

Digital health start-up Gendius has completed a series A undisclosed funding round to launch an app-based platform to help people living with diabetes better manage their condition. The Cheshire-based company secured the undisclosed investment from the GM&C Life Sciences Fund, which is managed by Catapult Ventures.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Nov 10,2017

Welkin Health gets $8M to scale, build out patient relationship management offering

San Francisco-based Welkin Health, which which specializes in patient relationship management through messaging services and workflow organization, has raised $8 million in a new round led by Thrive Capital. This brings Welkin’s total funding to $12 million. San Francisco-based Welkin Health, which which specializes in patient relationship management through messaging services and workflow organization, has raised $8 million in a new round led by Thrive Capital. This brings Welkin’s total funding to $12 million.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES A